Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 24156

AbstractMaterial and MethodsResultsDiscussionConclusionAcknowledgementReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2023 | Month : October | Volume : 17 | Issue : 10 | Page : LC01 - LC05 Full Version

Opioid Dependence Syndrome and Quality of Life: A Facility-based Exploratory Study among Drug Addicts at a Tertiary Care Hospital of Kolkata, India


Published: October 1, 2023 | DOI: https://doi.org/10.7860/JCDR/2023/66497.18515
Manika Pal, Dipendra Narayan Goswami, Madhumita Dobe

1. Assistant Professor, Department of Community Medicine, ESI-PGIMSR and ESIC Medical College, Joka, Kolkata, West Bengal, India. 2. Formerly Professor, Department of Community Medicine, IPGMER, Kolkata, West Bengal, India. 3. Formerly Director Professor, Department of Health Promotion and Education, All India Institute of Hygiene and Public Health, Kolkata, West Bengal, India.

Correspondence Address :
Manika Pal,
Flat 2B, Surya Tower, 31, CC Ghosh Road, Kolkata-700008, West Bengal, India.
E-mail: drmanikapal@gmail.com

Abstract

Introduction: Opioid dependence syndrome is considered a chronic-relapsing medical illness that can affect the Quality of Life (QoL) of Injecting Drug Users (IDUs). They are at risk of contracting Human Immunodeficiency Virus (HIV) due to unsafe injection practices. Opioid Substitution Therapy (OST) is an effective treatment option for opioid dependence as well as HIV prevention and intervention among IDUs, subsequently improving their QoL.

Aim: To identify the opioids injected by addicts and evaluate QoL across different life areas among IDUs attending an OST centre. The authors also aimed to determine the factors affecting QoL regarding relationships with family and friends.

Materials and Methods: A facility-based, observational cross-sectional study was conducted on 168 IDUs at an OST centre in Calcutta National Medical College from April 2016 to March 2018. A predesigned and pretested structured schedule was used, which included socio-demographic characteristics, pattern of substance abuse, and HIV status. To evaluate QoL, the authors used a Likert scale with five domains specific to chronic diseases. Logistic regression was employed to determine associated factors with two QoL domains regarding relationships with family and friends. The Statistical Package for Social Sciences (SPSS) version 16.0 was used for data analysis.

Results: The mean age {Standard Deviation (±SD)} of the study participants was 36.53±9.514 years. The most common opioids injected by IDUs were buprenorphine (89.2%). Although QoL scores varied across different domains, it can be interpreted that the majority of participants had poor QoL. When assessing QoL in terms of relationships with family and friends, there was a significant association between better QoL and financial support {Adjusted Odds Ratios (AOR) Confidence Intervals (CI)} 2.550 (1.431-6.082), favourable living arrangements AOR(CI) 2.450 (1.010-4.443), and absence of seropositivity AOR(CI) 2.462 (1.141-7.476).

Conclusion: Buprenorphine was the most common substance of abuse among IDUs. The study revealed a high proportion of IDUs with poor QoL. The findings of the study might be helpful in designing appropriate strategies to improve personal relationships and social situations among IDUs.

Keywords

Buprenorphine, Chronic disease, Drug users, Human immunodeficiency virus, Opioid substitution therapy, Personal satisfaction

Substance use disorders are chronic relapsing conditions that significantly impact health and social functioning among addicts, consequently affecting QoL across various life domains (1),(2). Opioid dependence syndrome is considered a chronic medical illness, and the majority of Injecting Drug Users (IDUs) are dependent on some form of injectable opioids (3),(4),(5). While there is considerable variation in the choice of drugs for injection among IDUs, many prefer short-acting illicit street opioids that provide instant euphoria (6). IDUs have emerged as an important high-risk group for Acquired Immunodeficiency Syndrome (AIDS), with the potential to contract and transmit HIV infection among themselves and society at large (3),(4),(5),(7). HIV transmission among IDUs primarily occurs through sharing contaminated injecting equipment and engaging in high-risk sexual behaviour (4),(5).

Needle Syringe Programmes (NSPs) and Opioid Substitution Therapy (OST) are two core interventions aimed at preventing HIV/AIDS among IDUs. NSPs distribute sterile needle-syringes to IDUs to prevent sharing of contaminated needles. OST, on the other hand, stabilises opioid-dependent IDUs by prescribing long-acting substitute opioids (such as Buprenorphine or Methadone) orally or sublingually, thereby helping them abandon their injecting habit. OST is an effective measure for HIV prevention and an opioid dependence treatment (3),(4). To diagnose dependence syndrome for a particular substance, certain criteria must be met, including: 1) Prolonged use of the substance in high doses despite self-harm; 2) Development of tolerance; 3) Experience of withdrawal symptoms and cravings; and 4) Significant socio-occupational dysfunction (4),(8),(9).

In OST, a long-acting opioid is administered orally under medical supervision for an extended period. Oral opioids alleviate withdrawal distress and subsequent cravings for illicit injectable opioids. Medically prescribed oral opioids are less euphoric but have a longer duration of action compared to street opioids (6). As a result, IDUs are maintained in a stable state that neither produces intoxication nor withdrawals or cravings. It is worth noting that among illegal substances, opioid dependence contributes the most to the number of disability-adjusted life years lost (9.2 million) and drug-related deaths (43.5 deaths per million people aged 15-64 years) (1),(2). The World Health Organisation (WHO) defines QoL as “individuals’ perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards, and concerns” (10). Gill TM and Feinstein AR, however, defined QoL as a reflection of respondents’ perceptions and reactions not only to their mental and physical health but also to non health-related aspects of their lives (e.g., family, friends, work). Therefore, measuring QoL needs to encompass more than just the health-related aspects of respondents’ lives (11).

The uniqueness of opioid dependence syndrome as a chronic relapsing disease among IDUs makes it critical to capture both the health-related and non health-related aspects of their lives that are important components of their QoL, particularly given their individual circumstances and environment. Opioid dependence syndrome is not a weakness of willpower or a “character defect” in addicts. Relapse is part of the recovery process, and there are strategies available to minimise relapse (4). Among addicts, domain-specific measures are fundamentally important as they consider various life domains simultaneously (e.g., subjective QoL profile) and produce subscores for different domains (multidimensional). The lives of IDUs revolve around the use of illicit opioids, while other domains of life take a back seat (4). As a consequence, IDUs become detached from their families and disconnected from society. Soon, they face social exclusion as their lives are shaped by the dual curse of addiction and low self-esteem. OST stabilises the social situation of opioid-dependent individuals (7),(8),(12).

The QoL of patients in Opioid Substitution Treatment (OST) has been extensively studied among IDUs in developed countries (13),(14). However, relatively few studies on this topic are available in less-resourced countries (15),(16). This prompted authors to conduct the current study on QoL among IDUs dependent on opioids, which was essentially part of a comprehensive research project among IDUs at the first Government OST centre in the city of Kolkata, exploring their high-risk behaviours, treatment compliance and retention in OST, as well as the stigma and discrimination they perceived. Hence, the objectives of the present study were to identify the illicit opioids injected by IDUs, assess QoL across different life domains among IDUs attending an OST centre, and determine the factors affecting QoL regarding relationships with family and friends.

Material and Methods

A facility-based, observational cross-sectional study was conducted at an OST centre in Calcutta National Medical College from April 2016 to March 2018. The novelty of the study was assessed by the Institutional Review Board of the All India Institute of Hygiene and Public Health. Approval was subsequently obtained from the Ethics Committees of Calcutta National Medical College. IEC NUMBER: CNMC/8 dated 11.05.16.

Inclusion criteria: The IDUs who inject opioids, aged over 18 years and agreed to provide informed written consent were included in the study.

Exclusion criteria: The IDUs in the induction phase of OST and IDUs with severe cognitive deficits were excluded from the study.

Study Procedure

A total of 198 IDUs were enrolled in the OST centre. IDUs visited the OST centre daily as it was a directly observed therapy that required daily attendance. A register was maintained at the centre, and a complete enumeration was done. Out of all the attendees, 168 met the inclusion criteria. Therefore, a total of 168 IDUs were recruited using the census method.

Study tool:

Structured schedule: A predesigned and pretested structured questionnaire was used, which included socio-demographic characteristics, pattern of substance abuse, HIV status, and other co-morbidities. Initially, a semistructured questionnaire was developed by the authors of the institutes. Subsequently, a pilot study was conducted with the help of a Peer Educator among 30 IDUs selected from nearby hotspots (IDU-TI). The acceptability and feasibility of the questionnaire were examined, and necessary changes were made following the pilot study before finalising the questionnaire.
Quality of Life Scale (QoLS): The QoLS is an instrument used to evaluate global QoL for chronic diseases (17). It is a reliable and valid instrument for measuring QoL from the patients’ perspective (18).

This validated instrument consisted of 15 items that measure five potentially independent QoL domains: (1) Physical and material well-being; (2) Relations with other people; (3) Social, community, and civic activities; (4) Personal development and fulfillment; and (5) Recreation. The scale ranges from “terrible” (1) to “delighted” (7), with higher scores indicating better QoL. The internal consistency of the scale (Bengali Vernacular) was computed using Cronbach’s alpha, and a value of 0.6 or more was considered acceptable (19). Each IDU was required to answer these items, even if they did not experience the life events (e.g., not married or having children).

While assessing global QoL, IDUs who achieved scores above the median of the attained score in a particular domain were considered to have better QoL in that domain. In the current study, the social relationships domain was explored, which included questions pertaining to satisfaction with personal relationships, social support systems, and sexual satisfaction. The different domains of the Quality of Life Scale are shown in the following (Table/Fig 1)a.

Three to five participants were interviewed per day, one day per week at the OST centre. The purpose of the study was explained to the participants, and informed consent was obtained. Face-to-face interviews were conducted at the OST centre, ensuring confidentiality. Records were also reviewed.

The outcomes variables studied were: Opioids of abuse among IDUs and Quality of Life (QoL) in different life domains. Predictor variables for better QoL in terms of social relationships (Domain-2): Financial support, living arrangement, educational level, HIV status, and co-morbidity (other than HIV). These predictor variables were identified by the researchers based on a review of the literature (20),(21),(22),(23).

Statistical Analysis

The SPSS version 16.0 was used for data analysis. Descriptive statistics were used to summarise the data. The association between better QoL and predictor variables was examined using univariate logistic regression. Odds Ratios (OR) with 95% Confidence Intervals (CI) were computed. Explanatory variables found to be statistically significant in univariate logistic regression were entered into multivariable logistic regression, and a p-value of <0.05 was considered statistically significant.

Results

Out of 168 IDUs who met the inclusion criteria and were approached to participate, 167 agreed, resulting in a response rate of 99.4%.

As shown in (Table/Fig 1)b, the mean age {Standard Deviation (±SD)} of the study participants was 36.53 (±9.514) years. The majority (98.2%) of the participants were males. A total of 67% of the participants had a low educational level. A total of 67 (40.1%) out of 167 IDUs were currently married.

Buprenorphine was the most commonly used substance among the injectable opioids, with 149 (89.2%) participants reporting its use (Table/Fig 2).

It is worth mentioning that the mean score for each domain was well below the scale mean for that domain (Table/Fig 3). The Mean (±SD) QoL score was found to be 39.79±3.26.

(Table/Fig 4) shows that nearly two-thirds of the IDUs experienced poor QoL in domains 2, 3, and 4. Out of 167 IDUs 18.6% tested positive for HIV, and no participants were positive for Hepatitis B (Table/Fig 5)a. A total of 70.7% of the IDUs did not have any co-morbidity, while 20.4% (34) had hypertension (Table/Fig 5)b.

The responses of the study participants were not normally distributed, so the idea of using linear regression with the total average score was abandoned. The domains were considered potentially independent, and focus was given to the social relationship domains. Participants were dichotomised based on the median score attained in domain-2. IDUs with a score above the median were considered to have better QoL in terms of relationships (domain-2).

As for the relationship with family and friends, domain-2 was further explored. The association between better QoL regarding social relationships and different independent variables was examined using univariate and multivariable logistic regression. All four explanatory variables that were found to be associated with a higher QoL score in domain-2 were entered into multivariable logistic regression for adjustment (Table/Fig 6)a.

(Table/Fig 6)b shows that three explanatory variables- absence of HIV infection, favourable living arrangement, and financial support were associated with better QoL in terms of relationships with family and friends. These associations were statistically significant. IDUs without HIV infection had 2.462 (1.141-7.476) times higher odds of having a higher QoL score in domain-2 compared to those with seropositivity. Similarly, IDUs who had financial support were 2.550 (1.431-6.082) times more likely to have a higher QoL score in domain-2 compared to those without financial support. Likewise, IDUs who had a favourable living arrangement (stable home) were 2.450 (1.010-4.443) times more likely to have a higher QoL score in domain-2 compared to those with unstable housing.

Discussion

In the present facility-based exploratory study, the researchers examined the pattern of psychoactive substance use and its impact on the QoL among individuals with opioid dependence syndrome. The findings of the current study shed light on the preferences of IDUs regarding opioid substances and the domains of life affected by their addiction. The analysis of the data revealed several important insights that contribute to authors’ understanding of opioid dependence syndrome and its impact on QoL.

The study highlighted notable variations in the choice of psychoactive substances among IDUs. The majority of participants (89.2%) preferred illegally procured street opioids, particularly injection buprenorphine, followed by pure heroin consumption (15.6%). This aligns with the broader trends seen in India, where opioids emerge as the primary substances of choice, often used in conjunction with other injectable psychoactive agents such as benzodiazepines or antihistamines [4,6]. Heroine and dextropropoxyphene are commonly used opioids in the northeastern states of India [4,25]. In metropolitan cities like Delhi, Mumbai, Chennai, and Kolkata, impure heroin, smack, and buprenorphine are the most commonly used opioids. In states such as Karnataka, Andhra Pradesh, Chhattisgarh, etc., pentazocine is the commonly injected opioid. In Punjab and Haryana, buprenorphine is the opioid of choice for injection (4).

Regarding the QoL analysis, the present study uncovered consistently low QoL scores across different life domains among the majority of the participants. Notably, the mean scores in each domain were significantly lower than the scale mean, suggesting a generally poor QoL for the majority of the participants. In particular, domain-2 (Relation with other people), encompassing aspects like family relations, raising children, spousal relations, and friendships, had been explored. Furthermore, within domain-2, as low as 34.7% of participants achieved scores above 9, indicating challenges faced by the addicts in maintaining healthy relationships.

Intriguingly, the present study revealed three predictors associated with an improved QoL in domain-2: (a) Absence of HIV infection; (b) Financial support; and (c) Favourable living arrangement. This aligns with previous research, such as the study by Castillo I, which identified that financial support was associated with better QoL (20). Similarly, a cross-sectional study conducted by Yen YF et al., among IDUs in Taipei, demonstrated that social support and income from temporary jobs were linked to better Health-related QoL (HRQoL) (21). The present study corroborated these findings by indicating that HIV positivity was associated with a poorer QoL in Domain-2 (Relation with other people).

Comparative studies have described the multifaceted nature of factors affecting QoL among drug users. For instance, Conroy E et al., explored the impact of family, health, housing, money, and partnerships on the QoL of IDUs in Australia (22). The study’s outcomes resonated with the present findings, particularly the positive influence of financial support on QoL. A case-control study conducted by Lee TSH et al., in northern Taiwan examined QoL among IDUs with HIV/AIDS, in comparison to the IDUs without HIV/AIDS. The study revealed that the four domains of QoL were significantly higher among IDUs without HIV compared with those with HIV (23). Similarly, in the present study, HIV positivity was associated with poor QoL in domain-2. Pant SB et al., in their study showed that QoL scores were significantly lower in the IDU group across all the domains in a bivariate analysis, but on multivariate analysis, this was only significant for the physical domain (26).

The present research echoes the global call for enhanced exploration of QoL among drug users, as noted by De Maeyer J et al., (27). While some studies tangentially address QoL, comprehensive research with a central focus on various life components influencing overall well-being is essential. To the best of authors’ knowledge, the present study is the first study on the QoL among addicts attending this Opioid Substitution Therapy (OST) centre. The present study revealed that a large proportion of addicts had experienced poor QoL. The findings of the study can be used to design appropriate strategies to improve QoL among Injection Drug Users (IDUs). The uniqueness of the current study was that the researchers considered opioid dependence syndrome to be a chronic relapsing disease among IDUs. Essentially, IDUs were portrayed as patients in need of treatment, rather than just one of the high-risk groups for HIV/AIDS or individuals who inject drugs. Moreover, when assessing QoL from their perspective, each domain of life was seen as a distinct entity.

Limitation(s)

One potential limitation of the present study was recall bias, as the information collected relied heavily on participants’ self-reporting based on their memory. Because of social desirability, some answers may have been biased and inaccurate, particularly for sensitive questions. Other limitations included a small sample size and a lack of generalisability. Linear regression with the total QoL score and predictor variables was not possible as the responses were not normally distributed.

Conclusion

In conclusion, the present study provided valuable insights into the opioid preferences among IDUs and the impact of opioid dependence on QoL across different domains. The study findings revealed the significance of factors such as financial support, living arrangements, and HIV infection in shaping the QoL of individuals struggling with opioid dependence, particularly in terms of their relationships with family and friends. As further investigations continue to uncover the complex relationships between substance use and subjective well-being, we can gain a more comprehensive understanding of the challenges faced by this vulnerable population.

Acknowledgement

The authors would like to acknowledge John C. Flanagan, Carol S. Burckhardt, and Kathryn L. Anderson, as the QoL scale used in the present study was adapted from theirs. The authors also acknowledge Professor (Dr.) A Mukhopadhyay from the Department of Psychiatry, Calcutta National Medical College.

References

1.
United Nations Office on Drugs and Crime. World Drug Report 2016. United Nations publication, Sales No. E.16.XI.7.
2.
Degenhardt L, Whiteford HA, Ferrari AJ, Baxter AJ, Charlson FJ, Hall WD, et al. Global burden of disease attributable to illicit drug use and dependence: Findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1564-74. Doi: 10.1016/S0140-6736(13)61530-5. Epub 2013 Aug 29. PMID: 23993281. [crossref][PubMed]
3.
Park K. Park’s Textbook of Preventive and Social Medicine. 26 th ed. Jabalpur, India: M/s Banarsidas Bhanot Publishers; 2021. Pp. 391-94.
4.
Rao R, Agrawal A, Ambekar A. Opioid substitution therapy under National AIDS control programme: Clinical practice guidelines for treatment with buprenorphine. Department of AIDS Control, Ministry of Health and Family Welfare, Government of India, New Delhi. 2014.
5.
Vickerman P, Degenhardt L, Hickman M. The impact of opiate substitution therapy and highly active antiretroviral therapy on mortality risk among people who inject drugs. Clin Infect Dis. 2015;61(7):1166-68. Doi: 10.1093/cid/civ481. [crossref][PubMed]
6.
Rao R, Agrawal A, Ambekar A. Methadone Maintenance Treatment Under National AIDS Control Programme: Practice Guideline. National AIDS Control Organisation, Ministry of Health and Family Welfare, Government of India, New Delhi.2017. https://www.lgbrimh.gov.in/resources/Addiction_Medicine/elibrary/ methadone_maintenance.pdf.
7.
Spire B, Lucas GM, Carrieri MP. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). Int J Drug Policy. 2007;18(4):262- 70. Doi: 10.1016/j.drugpo.2006.12.014. Epub 2007 Jan 26. PMID: 17689374. [crossref][PubMed]
8.
Tripathi KD. Opioid analgesic and antagonist. Essentials of medical pharmacology, 8th ed. New Delhi, India: Jaypee Brothers Medical Publishers Pvt., Ltd; 2019. Pp. 497-517.
9.
Gutstein HB, Akil H. Opioid analgesics. In: Hardman JG, Limbird LE, editors. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 11th ed. New York: McGraw-Hill; Pp. 569-84.
10.
World Health Organization (WHO). The World Health Organization Quality of Life (WHOQOL) [Internet]. Geneva: WHO; 2012. Available from: https://www.who.int/ tools/whoqol.
11.
Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA. 1994;272(8):619-26. PMID: 7726894. [crossref][PubMed]
12.
Yadav D, Ambekar A, Sethi H. OST program in Government health care settings: Treatment compliance and retention. Technical Report. 2012. Doi: 10.13140/ RG.2.1.1754.9920.
13.
De Maeyer J, Vanderplasschen W, Lammertyn J, van Nieuwenhuizen C, Sabbe B, Broekaert E. Current quality of life and its determinants among opiate-dependent individuals five years after starting methadone treatment. Qual Life Res. 2011;20(1):139-50. https://doi.org/10.1007/s11136-010-9732-3. [crossref][PubMed]
14.
Strada L, Franke GH, Schulte B, Reimer J, Verthein U. Development of OSTQOL: A measure of quality of life for patients in opioid substitution treatment. Eur Addict Res. 2017;23(5):238-48. Doi: 10.1159/000484239. Epub 2017 Nov 21. PMID: 29161720. [crossref][PubMed]
15.
Dhawan A, Rao R, Ambekar A, Chopra A, Jain R, Yadav D, et al. Methadone Maintenance Treatment in India: A feasibility and effectiveness Report. UNODC (ROSA) and NDDTC (AIIMS), New Delhi, India. 2014.
16.
Nair R, Nair SS, Malhotra S, Sachdeva A. Shifting trends of HIV epidemiology among most at risk groups (MARGs) in India. Int J Med Sci Public Health. 2012;1(2):18-31. [crossref]
17.
Flanagan JC. A research approach to improving our quality of life. American Psychologist. 1978;33(2):138-47. https://doi.org/10.1037/0003-066X.33.2.138. [crossref]
18.
Burckhardt CS, Anderson KL. The Quality of Life Scale (QOLS): Reliability, validity, and utilization. Health Qual Life Outcomes. 2003;1:60. https://doi.org/ 10.1186/1477-7525-1-60. [crossref][PubMed]
19.
Creswell JW. Educational research- planning, conducting, and evaluating quantitative and qualitative research, (4th Ed.), Pearson Merril Prentice Hall, New Jersey. (2010).
20.
Castillo I. Injection drug user Quality of Life scale (IDUQoL): Psychometric assessment of the Spanish version. Adicciones. 2008;20(3):281-94. PMID: 18813774.
21.
Yen YF, Chou P, Lin YS, Deng CY. Factors associated with health-related quality of life among injection drug users at methadone clinics in Taipei, Taiwan. J Chin Med Assoc. 2015;78(5):292-98. [crossref][PubMed]
22.
Conroy E, Kimber J, Dolan K, Day C. An examination of the quality of life among rural and outer metropolitan injecting drug users in NSW, Australia. Addiction Research and Theory. 2008;16(6):607-17. [crossref]
23.
Lee TSH, Shiu CS, Tuan YC, Wu WH, Huang CW, Yen MY, et al. Quality of life among injection drug users living with or without HIV/AIDS in Taiwan: A case control group design. J AIDS Clin Res. 2013;4(3):199. Doi: 10.4172/2155- 6113.1000199.
24.
Khairnar M, Wadgave U. Updated BG Prasad socioeconomic classification for 2016. J Indian Assoc Public Health Dent. 2016;14(4):469-70. Doi: 10.4103/2319- 5932.195832. [crossref]
25.
WHO/UNODC/UNAIDS position paper. Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention. World Health Organization, United Nations Office on Drugs and Crime, Joint United Nations Programme on HIV/AIDS, 2004.
26.
Pant SB, Thapa SB, Howard J, Ojha SP, Lien L. Psychological distress and quality of life among opioid agonist treatment service users with a history of injecting and non-injecting drug use: A cross-sectional study in Kathmandu, Nepal. PLOS One. 2023;18(2):e0281437. Doi: 10.1371/journal.pone.0281437. PMID: 36745666; PMCID: PMC9901755. [crossref][PubMed]
27.
De Maeyer J, Vanderplasschen W, Broekaert E. Quality of life among opiate- dependent individuals: A review of the literature. Int J Drug Policy. 2010;21(5):364- 80. Doi: 10.1016/j.drugpo.2010.01.010. Epub 2010 Feb 20. PMID: 20172706.[crossref][PubMed]

DOI and Others

DOI: 10.7860/JCDR/2023/66497.18515

Date of Submission: Jul 13, 2023
Date of Peer Review: Aug 07, 2023
Date of Acceptance: Sep 22, 2023
Date of Publishing: Oct 01, 2023

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Jul 14, 2023
• Manual Googling: Aug 16, 2023
• iThenticate Software: Sep 19, 2023 (12%)

ETYMOLOGY: Author Origin

EMENDATIONS: 8

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com